| Amy Adele Jacoby-loftis, LCSW / LMHP | |
|
7215 Ontario St, Omaha, NE 68124-3574 | |
| (531) 999-7120 | |
| Not Available |
| Full Name | Amy Adele Jacoby-loftis |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 7215 Ontario St, Omaha, Nebraska |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750088225 | NPI | - | NPPES |
| 1184332918 | Other | NE | CLINIC NPI |
| 1265422562 | Other | NE | ASSOCIATED PROVIDER NPI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | 5603 (Nebraska) | Secondary |
| 1041C0700X | Social Worker - Clinical | 1987 (Nebraska) | Primary |
| Entity Name | Pride Health Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184332918 PECOS PAC ID: 1153792478 Enrollment ID: O20230125000818 |
News Archive
Cells are generally able to repair spontaneous damage that arises in their genetic material. Unfortunately, the DNA repair process is not perfect and sometimes, damaged DNA gets passed on to newly made cells. A team of researchers at the Center for Molecular Biology of Heidelberg University has recently discovered that in yeast cells, the amount of nutrients that cells are exposed to can affect DNA surveillance and repair mechanisms and therefore the quality of their DNA.
With millions of Americans making it their New Year's resolution to lose weight and lead a healthier lifestyle, and with the cost of some diet programs rising as high as $10,000 per year, Nutrisystem has been credited by two of the nation's most respected media outlets for helping consumers shed pounds without lightening their wallets.
Shuaiyi International New Resources Development Inc. ("Shuaiyi" or the "Company"), a leading nutraceutical company focusing on the advanced technology related to the development of engineered "Cordyceps Militaris" in China, today announced the closing of a private placement with a group of accredited investors, pursuant to which the Company issued 1 million shares of the Company's common stock at a purchase price of $2.50 per share, for an aggregate purchase price of $2.5 million.
The two researchers are among the first to address the issue of drug shortages in contexts outside of the US; their study will look at the supply of medicines in Europe, with a focus on Germany, Austria and Switzerland.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amy Adele Jacoby-loftis, LCSW / LMHP 1650 S Topaz Way, Meridian, ID 83642-4474 Ph: (208) 605-7070 | Amy Adele Jacoby-loftis, LCSW / LMHP 7215 Ontario St, Omaha, NE 68124-3574 Ph: (531) 999-7120 |
News Archive
Cells are generally able to repair spontaneous damage that arises in their genetic material. Unfortunately, the DNA repair process is not perfect and sometimes, damaged DNA gets passed on to newly made cells. A team of researchers at the Center for Molecular Biology of Heidelberg University has recently discovered that in yeast cells, the amount of nutrients that cells are exposed to can affect DNA surveillance and repair mechanisms and therefore the quality of their DNA.
With millions of Americans making it their New Year's resolution to lose weight and lead a healthier lifestyle, and with the cost of some diet programs rising as high as $10,000 per year, Nutrisystem has been credited by two of the nation's most respected media outlets for helping consumers shed pounds without lightening their wallets.
Shuaiyi International New Resources Development Inc. ("Shuaiyi" or the "Company"), a leading nutraceutical company focusing on the advanced technology related to the development of engineered "Cordyceps Militaris" in China, today announced the closing of a private placement with a group of accredited investors, pursuant to which the Company issued 1 million shares of the Company's common stock at a purchase price of $2.50 per share, for an aggregate purchase price of $2.5 million.
The two researchers are among the first to address the issue of drug shortages in contexts outside of the US; their study will look at the supply of medicines in Europe, with a focus on Germany, Austria and Switzerland.
› Verified 4 days ago